financetom
Business
financetom
/
Business
/
AGF Management Q1 Adjusted Net Income Falls While Revenue Rises; Increases Quarterly Dividend
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AGF Management Q1 Adjusted Net Income Falls While Revenue Rises; Increases Quarterly Dividend
Apr 8, 2025 5:40 AM

08:18 AM EDT, 04/08/2025 (MT Newswires) -- AGF Management (AGF-B.TO) on Tuesday reported a decrease in adjusted net income for the first quarter even as revenue rose. The company also increased its quarterly dividend to 12.5 cents per share compared with 11.5 cents per share in the prior quarter for both the Class B Non-Voting shares and the Class A Voting common shares.

The company reported adjusted net income attributable to equity owners of $32.1 million, or $0.48 adjusted diluted earnings per share, for the three months ended Feb. 28, compared with $33.7 million, or $0.51 adjusted diluted EPS, a year earlier. Total adjusted revenue for Q1 increased to $111.5 million compared with $103 million a year-ago.

Adjusted revenue from AGF Capital Partners fell to $23.6 million from $24.4 million a year earlier. The company noted that the year-over-year decrease was driven by change in fair value adjustments, offset by the consolidation of KCPL financial results.

"In a challenging market environment shaped by political change, we have excelled and continued to deliver on our strategy," said AGF Chief Executive Kevin McCreadie. "Our long-term approach aims to deliver on our strategic imperatives; while also ensuring we can thrive through changing market cycles and uncertainty."

The quarterly dividend will be payable on April 23, to shareholders of record on April 14.

AGF had total assets under management and fee-earning assets of $53.8 billion at the end of February compared with $45 billion at the end of February 2024.

Shares of the company closed down about 1% to $9.09 on Monday on the Toronto Stock Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AerCap Delivers First 2 777-300ERSF Passenger-to-Freighters Aircraft to Kalitta Air
AerCap Delivers First 2 777-300ERSF Passenger-to-Freighters Aircraft to Kalitta Air
Sep 15, 2025
07:38 AM EDT, 09/15/2025 (MT Newswires) -- AerCap ( AER ) said Monday it has delivered the first two Boeing ( BA ) 777-300ERSF passenger-to-freighter converted aircraft to Kalitta Air, including the prototype certification aircraft. The company said the planes, part of a seven-aircraft deal, arrived at Kalitta's Michigan facility last week. Kalitta, the launch operator for its 777-300ERSF program,...
Avanos Medical Acquires Nexus Medical for Undisclosed Sum
Avanos Medical Acquires Nexus Medical for Undisclosed Sum
Sep 15, 2025
07:40 AM EDT, 09/15/2025 (MT Newswires) -- Avanos Medical ( AVNS ) said Monday that it has acquired privately-held medical device company, Nexus Medical, for an undisclosed sum. The company said it financed the transaction with available cash and expects it to be immediately accretive to revenue growth and earnings per share. ...
New Found Gold Appoints Former Newfoundland Premier Andrew Furey to Board, Names New CFO and COO
New Found Gold Appoints Former Newfoundland Premier Andrew Furey to Board, Names New CFO and COO
Sep 15, 2025
07:38 AM EDT, 09/15/2025 (MT Newswires) -- New Found Gold ( NFGC ) Monday said former Newfoundland and Labrador Premier Dr Andrew Furey has joined its board as an independent director, effective immediately. Furey served as premier from August 2020 to May 2025. The company also named Hashim Ahmed chief financial officer, succeeding Michael Kanesvsky, who will assist with the...
Top Premarket Gainers
Top Premarket Gainers
Sep 15, 2025
07:41 AM EDT, 09/15/2025 (MT Newswires) -- Helius Medical Technologies ( HSDT ) stock was up more than 300% pre-bell Monday following a 3.1% gain in the previous session. Monte Rosa Therapeutics ( GLUE ) shares were 60% higher after the company said it formed a collaboration with Novartis (NVS) to develop degraders for the treatment of immune-mediated diseases. Envirotech...
Copyright 2023-2025 - www.financetom.com All Rights Reserved